Skip to main content

Challenge and Prize Competition Winners

Our program engages a diverse group of people from all over the country to collaborate and stimulate innovative ideas. See the winners from our Challenges. 

Challenge Winners

Targeted Genome Editor Delivery (TARGETED) Phase 1 2023 Challenge Winners

This Challenge aims to advance the cutting-edge research of targeted delivery systems for genome editors in somatic cells. Phase 1 covered two target areas: Programmable Delivery System for Gene Editing and Crossing the Blood-Brain Barrier.

Bias Detection Tools in Health Care Challenge

The Challenge aimed to improve clinician and patient trust in intelligence and machine learning through bias detection and mitigation tools for clinical decision support. The Challenge closed on March 1, 2023. 

LitCoin Natural Language Processing (NLP) Challenge

The Challenge aimed to advance some of the most promising technology solutions built with knowledge graphs. The Challenge launched on Nov. 9, 2021, and the first phase closed Dec. 23, 2021.

LitCoin Pilot Design Challenge

The Challenge sought to spur innovation by rewarding the most creative and effective plans to construct the LitCoin submission platform. The Challenge submission window closed on Oct. 31, 2022.

ASPIRE Reduction-to-Practice Challenge 2020

The Challenge aimed to spur the development of a comprehensive integrated platform for translational innovation in pain, opioid use disorder and overdose.

Rare Diseases Are Not Rare! 2020

The Challenge entrants created a gallery of social media and art submissions, from videos and poems to spoken-word performances and personal stories.

ASPIRE Design Challenges Winners 2018

The challenges encouraged innovative and catalytic approaches toward solving the opioid crisis by developing “A Specialized Platform for Innovative Research Exploration” (ASPIRE).

Rare Diseases Are Not Rare! 2018

The Challenge received nearly 50 submissions, including posters, videos, and poems from people around the country to help bring attention to rare diseases and encourage interest in medical research. 

Last updated on April 19, 2024